Li Xu

机构：Shandong University of Traditional Chinese Medicine · ORCID：0000-0001-6406-9806

发表论文 71 篇 · 总被引 1164 次 · h-index 20

代表论文

• PAGln, an Atrial Fibrillation-Linked Gut Microbial Metabolite, Acts as a Promoter of Atrial Myocyte Injury (2022 · Biomolecules · 被引 45)
• Prognostic value of plasma phenylalanine and gut microbiota-derived metabolite phenylacetylglutamine in coronary in-stent restenosis (2022 · Frontiers in Cardiovascular Medicine · 被引 20)
• A comparative study to determine the association of gut microbiome with schizophrenia in Zhejiang, China (2022 · BMC Psychiatry · 被引 19)
• The Impact of Sleep Disturbance on Gut Microbiota, Atrial Substrate, and Atrial Fibrillation Inducibility in Mice: A Multi-Omics Analysis (2022 · Metabolites · 被引 11)
• Laparoscopic and open liver resection for hepatocellular carcinoma with type 2 diabetes mellitus: multicenter propensity score-matched study (2023 · Hepatology International · 被引 10)
• Hepatic arterial infusion chemotherapy plus targeted therapy and immunotherapy versus systemic chemotherapy for advanced intrahepatic cholangiocarcinoma: a retrospective cohort study (2024 · International Journal of Surgery · 被引 9)